Medirom Healthcare Technologies (MRM) Cash & Equivalents (2022 - 2024)
Medirom Healthcare Technologies has reported Cash & Equivalents over the past 3 years, most recently at $2.2 million for Q4 2024.
- Quarterly results put Cash & Equivalents at $2.2 million for Q4 2024, up 201.16% from a year ago — trailing twelve months through Dec 2024 was $2.2 million (up 201.16% YoY), and the annual figure for FY2024 was $2.2 million, up 201.16%.
- Cash & Equivalents for Q4 2024 was $2.2 million at Medirom Healthcare Technologies, up from $719462.2 in the prior quarter.
- Over the last five years, Cash & Equivalents for MRM hit a ceiling of $4.3 million in Q4 2022 and a floor of $719462.2 in Q4 2023.
- Median Cash & Equivalents over the past 3 years was $2.2 million (2024), compared with a mean of $2.4 million.
- Biggest five-year swings in Cash & Equivalents: crashed 83.21% in 2023 and later skyrocketed 201.16% in 2024.
- Medirom Healthcare Technologies' Cash & Equivalents stood at $4.3 million in 2022, then crashed by 83.21% to $719462.2 in 2023, then skyrocketed by 201.16% to $2.2 million in 2024.
- The last three reported values for Cash & Equivalents were $2.2 million (Q4 2024), $719462.2 (Q4 2023), and $4.3 million (Q4 2022) per Business Quant data.